Schizophrenia Research
Volume 98, Issue 1 , Pages 79-83 , January 2008

The course of tardive dystonia in Afro Caribbean patients, a population-based study: The Curacao Extrapyramidal Syndromes Study: VII

  • P.N. van Harten

      Affiliations

    • Symfora Group Psychiatric Center, Amersfoort, The Netherlands
    • University Medical Center Groningen, Groningen, The Netherlands
    • Dr. D.R. Capriles Hospital, Curaçao, The Netherlands Antilles
    • Corresponding Author InformationCorresponding author. Symfora group, Psychiatric Center, P.O. Box 3051, 3800DB Amersfoort, The Netherlands.
    • ,
  • G.E. Matroos

      Affiliations

    • Psychiatric Association Antilles, Curaçao, The Netherlands Antilles
    • Dr. D.R. Capriles Hospital, Curaçao, The Netherlands Antilles
    • ,
  • J. Van Os

      Affiliations

    • South Limburg Mental Health Research and Teaching Network, EURON, Maastricht University, The Netherlands
    • The Division of Psychological Medicine, Institute of Psychiatry, London, England

Received 11 May 2007 ,Revised 8 September 2007 ,Accepted 12 September 2007.

References 

  1. Burke RE. Neuroleptic-induced tardive dyskinesia variants. In:  Lang AE,  Weiner WJ editor. Drug-induced movement disorders. New York: Futura publishing company; 2005;p. 257–285
  2. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982;32:1335–1346
  3. Broekema WJ, de Groot IW, van Harten PN. Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics — a European study. Pharm. World Sci. 2007;29:126–130
  4. Broggi G, Franzini A, Tringali G, Ferroli P, Marras C, Romito L, et al. Deep brain stimulation as a functional scalpel. Acta Neurochir., Suppl. 2006;99:13–19
  5. Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am. J. Psychiatry. 2004;161:414–425
  6. Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC. Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998–2000. J. Clin. Psychiatry. 2004;65:1377–1388
  7. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch. Gen. Psychiatry. 2006;63:1079–1087
  8. Kane JM. Tardive dyskinesia circa. Am. J. Psychiatry. 2006;163:1316–1318
  9. Kang UJ, Burke RE, Fahn S. Natural history and treatment of tardive dystonia. Neurology. 1986;36:S121
  10. Kang UJ, Burke RE, Fahn S. Tardive dystonia. Adv. Neurol. 1988;50:415–429
  11. Kasper S, Lowry AJ, Hodge A, Bitter I, Dossenbach M. Tardive dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America. Schizophr. Res. 2006;81:139–143
  12. Kiriakakis V, Bhatia KP, Quinn NP, Marsden CD. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain. 1998;121:2053–2066
  13. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 2005;353:1209–1223
  14. Patterson BD, Swingler D, Willows S. Prevalence of and risk factors for tardive dyskinesia in a Xhosa population in the Eastern Cape of South Africa. Schizophr. Res. 2005;76:89–97
  15. van Harten PN, Kahn RS. Tardive dystonia. Schizophr. Bull. 1999;25:741–748
  16. van Harten PN, Matroos GE, Hoek HW, Kahn RS. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia: the Curacao Extrapyramidal Syndromes Study: I. Schizophr. Res. 1996;19:195–203
  17. van Harten PN, Kamphuis DJ, Matroos GE. Use of clozapine in tardive dystonia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 1996;20:263–274
  18. Van Harten PN, Hoek HW, Matroos GE, Koeter M, Kahn RS. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III. Am. J. Psychiatry. 1998;155:565–567
  19. van Harten PN, Hoek HW, Matroos GE, van Os J. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curacao Extrapyramidal Syndromes Study V. J. Clin. Psychiatry. 2006;67:1920–1927
  20. Wojcik JD, Falk WE, Fink JS, Cole JO, Gelenberg AJ. A review of 32 cases of tardive dystonia. Am. J. Psychiatry. 1991;148:1055–1059
  21. Yassa R, Nair V, Dimitry R. Prevalence of tardive dystonia. Acta Psychiatr. Scand. 1986;73:629–633

PII: S0920-9964(07)00404-5

doi: 10.1016/j.schres.2007.09.010

Schizophrenia Research
Volume 98, Issue 1 , Pages 79-83 , January 2008

Article Tools